Compounds > tobramycin
Page last updated: 2024-08-23

tobramycin and Community Acquired Infection

tobramycin has been researched along with Community Acquired Infection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N1
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A1
Alfa, M; Kibsey, P; Loo, V; McGeer, A; Nigrin, J; Peirano, G; Pienaar, C; Pitout, JD; Richardson, D; Toye, B1
Bes, M; Cavalié, L; Decousser, JW; Etienne, J; Laurent, F; Robert, J; Tristan, A1
De'Angelis, C; Elligsen, M; Lathia, N; LePiane, F; Simor, A; Walker, SA; Walker, SE1

Other Studies

5 other study(ies) available for tobramycin and Community Acquired Infection

ArticleYear
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal

2007
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome

2007
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Bacterial Typing Techniques; beta-Lactamases; Canada; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections

2010
Panton-valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Community-Acquired Infections; Enterotoxins; Exotoxins; France; Humans; Kanamycin; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Superantigens; Tetracycline; Tobramycin

2011
Comparison of mortality between nosocomial and community-acquired febrile neutropenia patients treated initially with cefazolin plus tobramycin: retrospective chart review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Cohort Studies; Community-Acquired Infections; Cross Infection; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Survival Analysis; Tobramycin; Young Adult

2012